Covishield月产量6000万剂，Covaxin月产量2000万剂，印度的疫苗接种数量是个谜

Covishield output at 6 crore, Covaxn output at 2 crore doses/month; yet only 5 crore will be given by May-end

Covishield月产量6000万剂，Covaxn月产量2000万剂，但到5月底只能提供5000万剂

NEW DELHI: There is a mystery in India’s vaccination numbers that official figures don’t seem to be able to explain. The mystery is that going by both government declarations and those of the vaccine manufacturers, India is producing at least about 27 lakh doses a day on average even without taking Sputnik into account. Yet, vaccination in the first three weeks of May has averaged just 16.2 lakh doses and states are complaining of shortages.

新德里：印度的疫苗接种数量是个谜，官方数据似乎无法解释。令人不解的是，根据政府的声明和疫苗制造商的声明，即使不计算俄罗斯Sputnik疫苗，印度平均每天也至少生产270万剂疫苗。然而，5月前三周的疫苗接种平均只有162万剂，各邦都在抱怨疫苗短缺。

The government in an affidavit in the Supreme Court earlier this month averred that Serum Institute of India (SII) was producing 6.5 crore doses of Covishield a month and Bharat Biotech was producing 2 crore doses of Covaxn a month, which was to be enhanced to 5.5 crore doses a month by July. It also said Sputnik was expected to ramp up production from 30 lakh a month to 1.2 crore a month by July.

本月初，印度政府在最高法院的一份宣誓书中证实，印度血清研究所(SII)每月生产6500万剂Covishield，巴拉特生物技术公司)每月生产2000万剂Covaxn，到7月将增至每月5500万剂。还表示，预计到7月份，Sputnik的产量将从每月300万剂提高到每月1200万剂。

SII has itself repeatedly said its production is 60-70 million doses a month, that is 6-7 crore. Bharat Biotech CMD Krishna Ella also was on record saying the company was slated to produce 20 million doses in April and would produce 30 million in May.

SII一再表示，其每月产量为6000 - 7000万剂。巴拉特生物技术公司也公开表示，该公司计划在4月份生产2000万剂，5月份将生产3000万剂。

Let us take the lowest figure in each case. That would mean 8.5 crore doses of just Covishield and Covaxn in May. For a month with 31 days, that averages to 27.4 lakh doses a day. This is assuming that Bharat Biotech has been unable to reach the anticipated 3 crore doses this month and has produced only 2 crore as in April.

取各自的最低数，这意味着5月份仅Covishield和Covaxn的剂量就达8500万剂。在31天的一个月里，平均每天生产274万剂。这是假设巴拉特生物技术公司不能在本月达到预期的3000万剂，而在4月份只生产了2000万剂。

以下是印度时报读者的评论：译者：Jessica.Wu

Niloy Dutta

transparency is a joke in our country

透明度在我们国家就是个笑话

Ranjan

I think the state Govts are hoarding vaccines and then citing vaccine shortages or selling them in black market citing wastage.

我认为是各邦政府囤积疫苗，在黑市上出售，然后又说疫苗短缺。

Sameer

The shamless state governments were caught red handed spreading fake news about vaccines

无耻的邦政府被抓了个正着，他们散布有关疫苗的假新闻

Addicted2U Trade

PM is chaiwaala then why people are surprised

总理是个卖茶人，有什么好惊讶的

Victor

Sonia/ Rahul / Tharoor wanted them to make zero vaccines.

索尼娅/拉胡尔希望疫苗产量为0。

Saurabh Meshram

Government is not transparent with the numbers. They should explain the gap in numbers.

印度政府对这些数据并不透明，他们应该可以解释数字上的出入。

Pratibha Sapre

On recieving the vaccines , some states ( opp ruled) r not utilizing them & r just hoarding vaccines inorder to claim centre is not doing enuf.

一些邦（反对党执政的）拿到了疫苗后囤积起来，并没有用，然后声称中央提供的不够多。

Revanna Bl

Why do you speculate and create confusion . Shame on you. convey possitive message

你们为什么要瞎猜测，制造混乱，可耻，要传达积极的信息

Lokendra Chauhan

Direct procurement by the center and distribution was the best method. But States like Maharashtra, Punjab, Delhi wanted flexbility for states.

中央直接采购和分配是最佳的方式。但马哈拉施特拉邦、旁遮普邦和德里希望自己来操作。

Ajitkumar Pandit

25% for private is for those who can afford to pay. One thing must be borne in mind that. Bharat biotech & SII are not there to make charity. They do deserve to earn profit.

25%是留给那些有支付能力的人的。有一件事必须记住。巴拉特生物技术和印度血清研究所不是做慈善的，他们也应获得利润。

Saneview

Misleading report creating doubt against govt. Why such question? Why ca’nt reporter ask authorised govt sources and get proper answer?

误导性的报道，引发了对政府的怀疑，为什么要问这样的问题?

为什么记者不去问授权的政府消息来源，寻求答案?

Rishi

according to health ministry, 1.9 corore vaccines are still with state. Secondly, vaccines are kept for few days for batch testing before being released.

卫生部称，各邦还有1900万剂疫苗，其次，疫苗在发放前要保存几天进行批量检测。

Vilas Durge

This govt must be charged for genocide.

我们应当以种族灭绝罪起诉印度政府。

User

The ground reality is, Indian gov had nothing to do with the cabine production or researching as of March this year.

实际情况是，直到今年3月，印度政府都没有参与疫苗的生产或研发。

production is either lower govt is inflating to look good or exporting without saying publicly

要么就是实际产量低了，但政府为了好看把产量说高了，要么就是拿去出口了，没有公开

Shraddha Banerjee

Rather than putting such article based on assumptions, they should had approached these pharmaceutical companies for actual reasons behind such difference in production and supply and let people know. Don't let them keep making baseless assumptions at least.

应该找这些制药公司了解产量和供应量出入背后的实际原因，让人们了解，不要基于假设来写这样的文章，至少不要做出毫无根据的假设。

Arnav

SII is manufacturing vaccines for AstraZeneca under contract manufacturing and is therefore not free to give all supplies to India only. They will have to export part of production to other countries as per AstraZeneca instructions. This has been explained multiple times however media like yours can only cause panic rather explaining a rational view.

血清研究所签了合同，为阿斯利康生产疫苗，因此不能把所有疫苗都提供给印度。根据阿斯利康的指示，他们必须将部分疫苗出口到其他国家。这已经被解释过很多次了，你们这样的媒体只会引起恐慌。

Vinod Aggarwal

DONT TRY TO CREATE CONFUSION ...... TRY TO INVESTIGATE

不要试图制造混乱，去好好调查一下

Sandeep Bhatia

only central government should have control ...modi is running away from his responsibilities

印度政府应该管的，莫迪在逃避他的责任

Sandeep Kumar

This all mess created by center !!

这一切都是由印度中央政府造成的!!

Sudhi B

Looks like without court intervention nothing happens in a transparent manner in this country